The year 2020 was a year when the global pharmaceutical industry was profoundly affected by the epidemic. It was also a year when China’s API industry withstood the test of fluctuations in the international market. According to the preliminary statistics of China Chamber of Commerce for Medical Insurance, in 2020, China’s API exports reached us $35.7 billion, another record high, with a year-on-year growth of about 6%.
In conclusion, plastic fillers are integral to modern manufacturing, serving a multitude of functions that enhance both the performance and cost-effectiveness of polymer products. As technological advancements continue, the development of new fillers and formulations will likely lead to even greater applications and efficiencies, contributing to the ongoing evolution of materials science. The future of filled plastics promises innovations that not only meet consumer demands but also align with sustainability goals, shaping a greener and more efficient manufacturing landscape.
The liver plays a crucial role in metabolizing proteins and eliminating waste products from the body, including ammonia. Ammonia, a toxic byproduct of protein metabolism, is typically converted into urea in the liver—a process that allows for its safe excretion through urine. However, in cases of liver cirrhosis or hepatic encephalopathy, the liver's ability to process ammonia is compromised, leading to a dangerous accumulation.